D. Currie, here.
Showing posts with label competition and growth. Show all posts
Showing posts with label competition and growth. Show all posts
Thursday, October 01, 2015
Friday, July 10, 2015
Tuesday, October 21, 2014
Wednesday, April 09, 2014
Wednesday, April 24, 2013
Thursday, March 08, 2012
Wednesday, February 29, 2012
Thursday, December 01, 2011
Unleashing Europe’s potential for growth: The role of competition policy
J. Almunia, here.
From the speech: " Fair and robust competition rules mean – among other things – integrating those markets which, in practice, continue to operate at national level; promoting innovation; encouraging the restructuring of mature European industries; and fighting against protectionism" and "(R)ecently we have seen a rise in the strategic use of IPR. Take for example the mobile communications industry, where it seems that everybody is suing everybody else for patent infringements, often to block certain products from entering the market.
I have instructed my services to look closely into how intellectual property rights are used; for instance, we have recently asked Apple and Samsung to send us information on their patents for smartphones.
Our enforcement practice has also taught us that IPR strategies may be a concern also in the pharmaceutical industry.
In addition, we will soon be launching a stakeholder survey on the operation of the current antitrust regime of technology transfer agreements, which will expire in 2014.
An important issue will be to assess whether innovation is being properly disseminated to industries and consumers under the current regime."
From the speech: " Fair and robust competition rules mean – among other things – integrating those markets which, in practice, continue to operate at national level; promoting innovation; encouraging the restructuring of mature European industries; and fighting against protectionism" and "(R)ecently we have seen a rise in the strategic use of IPR. Take for example the mobile communications industry, where it seems that everybody is suing everybody else for patent infringements, often to block certain products from entering the market.
I have instructed my services to look closely into how intellectual property rights are used; for instance, we have recently asked Apple and Samsung to send us information on their patents for smartphones.
Our enforcement practice has also taught us that IPR strategies may be a concern also in the pharmaceutical industry.
In addition, we will soon be launching a stakeholder survey on the operation of the current antitrust regime of technology transfer agreements, which will expire in 2014.
An important issue will be to assess whether innovation is being properly disseminated to industries and consumers under the current regime."
Subscribe to:
Posts (Atom)
-
Full of amazing panels, you just have to watch them all - over the coming weeks and months, also because they'll even get better with ti...
-
M. Vestager, here . Letta Report here . Draghi's Géopolitiques Article here .
-
ECA, video here
-
Video soon available here .
-
ACM, here .